Navigation Links
Qforma Appoints Erin McLaughlin as Director, Field Operations
Date:10/29/2009

SANTA FE, N.M., Oct. 29 /PRNewswire/ -- Qforma, an advanced analytics and predictive modeling company, today announced the appointment of Erin McLaughlin to the position of director of field operations.

"Erin is a welcome addition to the Qforma family, and her appointment is the latest highlight in a year marked by company growth and important milestones," said Kelly D. Myers, CEO of Qforma. "Her combined background and expertise in analytics and healthcare will make her a perfect fit for our team and a valued asset to our customers."

As a director of field operations, McLaughlin will be responsible for consulting with the company's scientific team to design a customized project plan and specifications for each customer. She will work with customers throughout the solution implementation process to facilitate and track project progress, provide measurements of results during implementation and assist with final analysis of software deliverables.

McLaughlin comes to Qforma with more than 10 years of experience in the healthcare industry, in both an operational capacity and business development. She began her career with NDCHealth (now Wolters Kluwer Health), where she held positions in sales and management. Most recently, McLaughlin was an account manager with Surveillance Data Inc. (SDI), working with pharmaceutical and biotech company clients on the West Coast.

About Qforma

Qforma is an advanced analytics and predictive modeling company specializing in solutions for the pharmaceutical and biotech industries. Qforma leverages the talents of physicists, mathematicians and programmers, and has developed a unique approach to quantifying large data flows with the purpose of eliminating the inefficiencies of traditional sales and marketing techniques. In May 2009, Qforma launched "Most Influential Doctors" (MID), a first-of-its-kind online database presented by USA TODAY that provides consumers with information about the top community medical leaders in virtually every metropolitan area in the U.S. The recently expanded database is available at www.influentialdoctors.usatoday.com.

Qforma is headquartered in Santa Fe, NM, with offices in Princeton, NJ. More information is located at http://www.Qforma.com.

    Media Contacts:
    Lisa Haley, Qforma
    (505) 603-7596
    lhaley@qforma.com

    Jeff Hoyak, MCS Healthcare Public Relations
    (800) 477-9626, ext. 312
    jeffh@mcspr.com

SOURCE Qforma


'/>"/>
SOURCE Qforma
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. VitaminSpice Appoints Dr. Richard F. Seelig as Director
2. Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs
3. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
4. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
5. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
6. EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales
7. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
8. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
9. CeQur SA Appoints Eric Milledge Chairman of the Board of Directors
10. US HIFU Appoints Arie Belldegrun, M.D. to Board of Directors
11. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
Breaking Medicine Technology:
(Date:4/26/2017)... Aviv, Israel (PRWEB) , ... April 26, 2017 , ... ... today announced a new partnership with Med-e-Mass , the largest Electronic Medical Records ... enable Med-e-Mass to link care plan incentives to a patient’s remote health progress, empowering ...
(Date:4/26/2017)... ... ... Miami native and local periodontist Dr. John Paul Gallardo is ... in 1991 that this journey would have taken me into so many learning experiences ... Gallardo has pioneered implant dentistry innovation, evolving into an internationally recognized leader in the ...
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from ... performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, and ... important patterns in student test score performance, the report’s limited analyses fail to ...
Breaking Medicine News(10 mins):